ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Human Factors, Instrumentation & Controls
Improving task performance, system reliability, system and personnel safety, efficiency, and effectiveness are the division's main objectives. Its major areas of interest include task design, procedures, training, instrument and control layout and placement, stress control, anthropometrics, psychological input, and motivation.
Meeting Spotlight
Utility Working Conference and Vendor Technology Expo (UWC 2024)
August 4–7, 2024
Marco Island, FL|JW Marriott Marco Island
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
August 2024
Nuclear Technology
Fusion Science and Technology
Latest News
Vogtle-3 shuts down for valve issue
One of the new Vogtle units in Georgia was shut down unexpectedly on Monday last week for a valve issue that has since been investigated and repaired. According to multiple local news outlets, Georgia Power reported on July 17 that Unit 3 was back in service.
Southern Company spokesperson Jacob Hawkins confirmed that Vogtle-3 went off line at 9:25 p.m. local time on July 8 “due to lowering water levels in the steam generators caused by a valve issue on one of the three main feedwater pumps.”
James R. Powell, Hans Ludewig, Michael Todosow, Morris Reich
Nuclear Technology | Volume 125 | Number 1 | January 1999 | Pages 104-115
Technical Paper | Accelerators | doi.org/10.13182/NT99-A2936
Articles are hosted by Taylor and Francis Online.
Two new accelerator target and neutron filter concepts are proposed for boron neutron capture therapy (BNCT) to enable production efficiencies for epithermal neutrons (i.e., neutrons leaving the treatment port and neutrons generated in the target) of ~5 to 10%. These efficiencies are much greater than in previous designs and allow BNCT facilities to use near-term, low-current (~5 mA) proton accelerators. Two target/filter designs are described and their neutronic performance analyzed. In NIFTI-1, epithermal neutrons (maximum energy of ~100 keV) are generated by a proton beam that is maintained slightly above the 1.889-MeV threshold for the 7Li(p,n)7Be reaction. As the proton beam passes through the DISCOS target, which consists of a sequential series (e.g., total of 80) of very thin (several microns) liquid-lithium films on ultrathin rotating beryllium metal foils, the protons are reaccelerated by an applied direct-current field between the foils. This reacceleration enables a high total neutron yield, ~10-4 neutrons/proton. The NIFTI-1 neutron filter, a highly scattering cross-section layer of iron-magnesium, located between the target and the treatment port, impedes neutron transmission for energies >24 keV, but it has a deep window in the scattering cross section at 24 keV. Scattering in the filter and an accompanying thin (~1 cm) hydrogenous neutron "downshifter" yield a neutron output beam with an average energy of ~10 to 20 keV. In the NIFTI-2 design, a single thick lithium target is used, with a proton beam energy (~2.5 MeV) well above the (p,n) threshold. Although the neutron yield from the target is high, ~10-4 neutrons/proton, their energy is much greater (maximum of ~800 keV) than in NIFTI-1. The high-energy neutrons inelastically scatter in a fluorine-containing material (BeF2/PbF2) placed between the target and the NIFTI filter. The neutron beam out of the treatment port has an average energy of ~30 keV. The effectiveness of the two designs for BNCT treatment is analyzed. Both exhibit good penetration in tissue (advantage depth) and tumor/healthy tissue dose (relative biological effectiveness advantage ratio) performance.
